These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34438012)

  • 1. Cytoprotective agent troxipide-cyanine dye conjugate with cytotoxic and antiproliferative activity in patient-derived glioblastoma cell lines.
    Cooper E; Choi PJ; Schweder P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; I-H Park T; Jose J
    Bioorg Med Chem Lett; 2021 Oct; 50():128336. PubMed ID: 34438012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARP inhibitor cyanine dye conjugate with enhanced cytotoxic and antiproliferative activity in patient derived glioblastoma cell lines.
    Choi PJ; Cooper E; Schweder P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; Park TI; Jose J
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127252. PubMed ID: 32527552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthesis of a novel Crizotinib heptamethine cyanine dye conjugate that potentiates the cytostatic and cytotoxic effects of Crizotinib in patient-derived glioblastoma cell lines.
    Choi PJ; Cooper E; Schweder P; Mee E; Faull R; Denny WA; Dragunow M; Park TI; Jose J
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2617-2621. PubMed ID: 31378572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.
    Cooper E; Oyagawa CRM; Johnson R; Choi PJ; Foliaki JM; Correia J; Schweder P; Heppner P; Mee E; Turner C; Faull R; Denny WA; Dragunow M; Jose J; Park TI
    Cell Commun Signal; 2024 Jan; 22(1):30. PubMed ID: 38212807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of Dasatinib with MHI-148 Has a Significant Advantageous Effect in Viability Assays for Glioblastoma Cells.
    Usama SM; Jiang Z; Pflug K; Sitcheran R; Burgess K
    ChemMedChem; 2019 Sep; 14(17):1575-1579. PubMed ID: 31322832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temozolomide-Doxorubicin Conjugate as a Double Intercalating Agent and Delivery by Apoferritin for Glioblastoma Chemotherapy.
    Du K; Xia Q; Heng H; Feng F
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34599-34609. PubMed ID: 32648735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug-carrier molecule for the treatment of glioblastoma.
    Cooper E; Choi PJ; Hwang K; Nam KM; Kim CY; Shaban T; Schweder P; Mee E; Correia J; Turner C; Faull RLM; Denny WA; Noguchi K; Dragunow M; Jose J; Park TI
    Chem Biol Drug Des; 2023 Mar; 101(3):696-716. PubMed ID: 36323652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide.
    Johannessen TC; Hasan-Olive MM; Zhu H; Denisova O; Grudic A; Latif MA; Saed H; Varughese JK; Røsland GV; Yang N; Sundstrøm T; Nordal A; Tronstad KJ; Wang J; Lund-Johansen M; Simonsen A; Janji B; Westermarck J; Bjerkvig R; Prestegarden L
    Int J Cancer; 2019 Apr; 144(7):1735-1745. PubMed ID: 30289977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic Polyaminocarboxylate-Cyanine-Transferrin Conjugate for Anticancer Therapy and Near-Infrared Optical Imaging.
    Kang CS; Ren S; Sun X; Chong HS
    ChemMedChem; 2016 Oct; 11(19):2188-2193. PubMed ID: 27624789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
    Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
    BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway.
    Szeliga M; Karpińska M; Rola R; Niewiadomy A
    Bioorg Chem; 2020 Dec; 105():104362. PubMed ID: 33074121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma.
    Renziehausen A; Tsiailanis AD; Perryman R; Stylos EK; Chatzigiannis C; O'Neill K; Crook T; Tzakos AG; Syed N
    Mol Cancer Ther; 2019 Sep; 18(9):1497-1505. PubMed ID: 31213505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid PET tracers are reliable markers of treatment responses to single-agent or combination therapies including temozolomide, interferon-β, and/or bevacizumab for glioblastoma.
    Ono T; Sasajima T; Doi Y; Oka S; Ono M; Kanagawa M; Baden A; Mizoi K; Shimizu H
    Nucl Med Biol; 2015 Jul; 42(7):598-607. PubMed ID: 25892210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artesunate enhances the antiproliferative effect of temozolomide on U87MG and A172 glioblastoma cell lines.
    Karpel-Massler G; Westhoff MA; Kast RE; Dwucet A; Nonnenmacher L; Wirtz CR; Debatin KM; Halatsch ME
    Anticancer Agents Med Chem; 2014 Feb; 14(2):313-8. PubMed ID: 24506460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.
    Zhao M; Bozzato E; Joudiou N; Ghiassinejad S; Danhier F; Gallez B; Préat V
    J Control Release; 2019 Sep; 309():72-81. PubMed ID: 31306678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing drugs for glioblastoma: From bench to bedside.
    Basso J; Miranda A; Sousa J; Pais A; Vitorino C
    Cancer Lett; 2018 Aug; 428():173-183. PubMed ID: 29729291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel heptamethine cyanine dye-erlotinib conjugates as antitumor agents.
    Yang X; Hou Z; Wang D; Mou Y; Guo C
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127557. PubMed ID: 32949719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An anti-aggregation NIR-II heptamethine-cyanine dye with a stereo-specific cyanine for imaging-guided photothermal therapy.
    Qian H; Cheng Q; Tian Y; Dang H; Teng C; Yan L
    J Mater Chem B; 2021 Mar; 9(11):2688-2696. PubMed ID: 33667292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells.
    Goker Bagca B; Ozates NP; Asik A; Caglar HO; Gunduz C; Biray Avci C
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1497-1504. PubMed ID: 33109342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.